Research Paper Volume 15, Issue 22 pp 13287—13311
Molecular characteristics and clinical implications of serine/arginine-rich splicing factors in human cancer
Figure 2. The genomic alterations of SRSFs in human cancer. (A) Genomic alterations [non-silent mutation and SCNA] landscape in the SRSFs in 33 cancer types. (B) Distribution of mutation frequencies across cancer types. (C, D) Distribution of SCNA (C: CNV amplification; D: CNV deep deletion) frequencies across cancer types. The darkness of color is proportional to the frequency.